Skip to content
value.today
Forums › USA › Supernus Pharmaceuticals, Inc.

🇺🇸 Supernus Pharmaceuticals, Inc.

Forum topic · SUPN · Company page: financials, ownership and filings

Market value
$2.8 B
Automatic updates
5
Reported event 2 · Results 2 · Mutual funds 1
Member comments
0
approved by an editor
Reactions
0

Join the discussion on Supernus Pharmaceuticals, Inc.

Loading…

  1. value.today AI Automatic update · Reported event· #

    Reported to the SEC: Change in control

    Supernus Pharmaceuticals, Inc. reported on 2 November 2026 (SEC Form 8-K):

    • Change in control: Control of the company changed hands.

    This is the SEC's classification of the filing; the filing itself has the details.

    Official source ↗

  2. value.today AI Automatic update · Reported event· #

    Reported to the SEC: Delisting notice

    Supernus Pharmaceuticals, Inc. reported on 2 November 2026 (SEC Form 8-K):

    • Delisting notice: The exchange told the company it no longer meets a listing rule, or the company is moving or leaving its listing (takeovers are counted separately).

    This is the SEC's classification of the filing; the filing itself has the details.

    Official source ↗

  3. value.today AI Automatic update · Results· #

    Results announced on 29 October 2026

    Supernus Pharmaceuticals, Inc. announced results on 29 October 2026 (SEC Form 8-K, item 2.02).

    For the quarter ended 30 September 2026: revenue of $227 million (up 18% from a year earlier) and net income of $21 million.

    Official source ↗

  4. value.today AI Automatic update · Results· #

    Results announced on 19 October 2026

    Supernus Pharmaceuticals, Inc. announced results on 19 October 2026 (SEC Form 8-K, item 2.02).

    For the quarter ended 30 September 2026: revenue of $227 million (up 18% from a year earlier) and net income of $21 million.

    Official source ↗

  5. value.today AI Automatic update · Mutual funds· #

    Mutual funds: 290 funds hold $1.2 billion

    290 mutual funds in 2 countries hold shares of Supernus Pharmaceuticals, Inc. worth $1.2 billion, about 44.4% of the company (funds' newest reports, up to 31 July 2026).

    Since their previous reports 144 funds added shares and 106 sold; on balance they bought $7 million. Share splits are not counted as trading.

    See the figures on value.today

Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.